Sonya Sharp-Stenken

Sonya Sharp-Stenken is a seasoned professional in market access and national accounts within the pharmaceutical industry, currently serving as Sr. Director of National Accounts at UroGen Pharma since June 2019. With prior experience as Director of Market Access at Dendreon and Corporate Account Director at MT Pharma America, Inc., Sonya has a proven track record in managing teams and driving successful product launches. Additional roles include Regional Director of Market Access at Otsuka Pharmaceutical Companies and Director of National Accounts at Amarin Corporation, where significant contributions were made to market strategy and payer relations. Sonya’s expertise is backed by a Master of Business Administration in Marketing & Management from Xavier University and a Bachelor of Business Administration from the University of Cincinnati.